seed
Stage
2023
Founded
1
Investors
About
Sable Bio develops an AI-powered platform that integrates and analyzes safety data from clinical, genetic, experimental, and literature sources to help toxicologists prioritize and mitigate toxicology risks in drug discovery, enabling faster, more accurate safety assessments.
Explore Sable Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.